1,1-dichloroethene decreases expression ISO RGD:732633 6480464 vinylidene chloride results in decreased expression of EBF1 mRNA CTD PMID:26682919 17alpha-ethynylestradiol multiple interactions ISO RGD:732633 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of EBF1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of EBF1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol decreases expression ISO RGD:732633 6480464 Ethinyl Estradiol results in decreased expression of EBF1 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:732633 6480464 Estradiol results in decreased expression of EBF1 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF1 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF1 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:732633 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:732633 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732633 6480464 Tetrachlorodibenzodioxin results in decreased expression of EBF1 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EBF1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EBF1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1349579 6480464 Tetrachlorodibenzodioxin results in decreased expression of EBF1 mRNA CTD PMID:29107001 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732633 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of EBF1 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to EBF1 promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol decreases expression ISO RGD:732633 6480464 n-butoxyethanol results in decreased expression of EBF1 mRNA CTD PMID:19812364 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349579 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:732633 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of EBF1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:732633 6480464 Fenretinide results in decreased expression of EBF1 mRNA CTD PMID:28973697 aflatoxin B1 decreases methylation ISO RGD:1349579 6480464 Aflatoxin B1 results in decreased methylation of EBF1 gene, Aflatoxin B1 results in decreased methylation of EBF1 intron CTD PMID:27153756 , PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1349579 6480464 aflatoxin B2 results in increased methylation of EBF1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1349579 6480464 Tretinoin results in increased expression of EBF1 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EBF1 mRNA CTD PMID:16483693 arotinoid acid multiple interactions ISO RGD:1349579 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsenite(3-) increases methylation ISO RGD:1349579 6480464 arsenite results in increased methylation of EBF1 promoter CTD PMID:23974009 atrazine decreases expression ISO RGD:1349579 6480464 Atrazine results in decreased expression of EBF1 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of EBF1 gene CTD PMID:28931070 benzo[a]pyrene multiple interactions ISO RGD:732633 6480464 Benzo(a)pyrene affects the reaction [AHR protein binds to EBF1 promoter] CTD PMID:19654925 benzo[a]pyrene increases methylation ISO RGD:1349579 6480464 Benzo(a)pyrene results in increased methylation of EBF1 exon, Benzo(a)pyrene results in increased methylation of EBF1 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:732633 6480464 Benzo(a)pyrene results in decreased methylation of EBF1 intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1349579 6480464 Benzo(a)pyrene results in decreased methylation of EBF1 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:732633 6480464 Benzo(a)pyrene results in increased expression of EBF1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of EBF1 mRNA CTD PMID:21839799 bis(2-chloroethyl) sulfide increases expression ISO RGD:732633 6480464 Mustard Gas results in increased expression of EBF1 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1349579 6480464 Diethylhexyl Phthalate results in decreased expression of EBF1 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1349579 6480464 bisphenol A results in decreased expression of EBF1 mRNA CTD PMID:22576693 bisphenol A decreases methylation ISO RGD:1349579 6480464 bisphenol A results in decreased methylation of EBF1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EBF1 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:1349579 6480464 bisphenol A results in increased expression of EBF1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1349579 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of EBF1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF1 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of EBF1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EBF1 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases methylation ISO RGD:1349579 6480464 bisphenol A results in increased methylation of EBF1 gene CTD PMID:22576693 buta-1,3-diene decreases expression ISO RGD:732633 6480464 1, 3-butadiene results in decreased expression of EBF1 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1349579 6480464 butyraldehyde results in decreased expression of EBF1 mRNA CTD PMID:26079696 carbon nanotube decreases expression ISO RGD:732633 6480464 Nanotubes, Carbon results in decreased expression of EBF1 mRNA CTD PMID:25554681 CHIR 99021 multiple interactions ISO RGD:1349579 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroprene decreases expression ISO RGD:732633 6480464 Chloroprene results in decreased expression of EBF1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:732633 6480464 Chlorpyrifos results in decreased expression of EBF1 mRNA CTD PMID:32715474 choline multiple interactions ISO RGD:732633 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EBF1 gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1349579 6480464 Cisplatin results in decreased expression of EBF1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1349579 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of EBF1 mRNA CTD PMID:27392435 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of EBF1 mRNA CTD PMID:26033743 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of EBF1 mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of EBF1 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of EBF1 mRNA CTD PMID:26033743 cortisol multiple interactions ISO RGD:1349579 6480464 [4-(2-(5 more ... CTD PMID:34480604 crocidolite asbestos increases expression ISO RGD:1349579 6480464 Asbestos, Crocidolite results in increased expression of EBF1 mRNA CTD PMID:18687144 crocidolite asbestos decreases expression ISO RGD:732633 6480464 Asbestos, Crocidolite results in decreased expression of EBF1 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of EBF1 mRNA CTD PMID:26577399 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of EBF1 mRNA CTD PMID:23640034 deguelin decreases expression ISO RGD:1349579 6480464 deguelin results in decreased expression of EBF1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1349579 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF1 mRNA CTD PMID:28628672 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of EBF1 mRNA CTD PMID:22911455 disodium selenite decreases expression ISO RGD:732633 6480464 Sodium Selenite results in decreased expression of EBF1 mRNA CTD PMID:23274088 diuron decreases expression EXP 6480464 Diuron results in decreased expression of EBF1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1349579 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1349579 6480464 Doxorubicin results in decreased expression of EBF1 mRNA CTD PMID:29803840 exemestane increases expression ISO RGD:1349579 6480464 exemestane results in increased expression of EBF1 mRNA CTD PMID:17254854 folic acid multiple interactions ISO RGD:732633 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EBF1 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:732633 6480464 Folic Acid results in decreased expression of EBF1 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1349579 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of EBF1 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of EBF1 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1349579 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF1 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:732633 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EBF1 gene CTD PMID:20938992 lithium chloride increases expression ISO RGD:732633 6480464 Lithium Chloride results in increased expression of EBF1 mRNA CTD PMID:27226553 melphalan decreases expression ISO RGD:1349579 6480464 Melphalan results in decreased expression of EBF1 mRNA CTD PMID:22363485 mercury dibromide decreases expression ISO RGD:1349579 6480464 mercuric bromide results in decreased expression of EBF1 mRNA CTD PMID:26272509 methylmercury chloride increases expression ISO RGD:1349579 6480464 methylmercuric chloride results in increased expression of EBF1 mRNA CTD PMID:23179753 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1349579 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of EBF1 mRNA CTD PMID:24810058 nickel atom decreases expression ISO RGD:1349579 6480464 Nickel results in decreased expression of EBF1 mRNA CTD PMID:25583101 niclosamide decreases expression ISO RGD:732633 6480464 Niclosamide results in decreased expression of EBF1 mRNA CTD PMID:27226553 O-methyleugenol decreases expression ISO RGD:1349579 6480464 methyleugenol results in decreased expression of EBF1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of EBF1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of EBF1 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid decreases expression ISO RGD:1349579 6480464 p-Chloromercuribenzoic Acid results in decreased expression of EBF1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1349579 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EBF1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1349579 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBF1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1349579 6480464 panobinostat results in increased expression of EBF1 mRNA CTD PMID:26272509 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of EBF1 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:732633 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1349579 6480464 [perfluorooctane sulfonic acid affects the methylation of EBF1 gene] which affects the expression of EBF1 mRNA CTD PMID:32653021 pirinixic acid multiple interactions ISO RGD:732633 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of EBF1 mRNA CTD PMID:20813756 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of EBF1 mRNA CTD PMID:12832660 pirinixic acid increases expression ISO RGD:732633 6480464 pirinixic acid results in increased expression of EBF1 mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO RGD:1349579 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of EBF1 mRNA CTD PMID:19710929 Ptaquiloside decreases expression ISO RGD:732633 6480464 ptaquiloside results in decreased expression of EBF1 mRNA CTD PMID:23274088 rotenone decreases expression ISO RGD:1349579 6480464 Rotenone results in decreased expression of EBF1 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1349579 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 sodium arsenite affects methylation ISO RGD:1349579 6480464 sodium arsenite affects the methylation of EBF1 gene CTD PMID:28589171 sodium arsenite affects expression ISO RGD:1349579 6480464 sodium arsenite affects the expression of EBF1 mRNA CTD PMID:29319823 , PMID:34032870 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF1 mRNA CTD PMID:32741896 thapsigargin decreases expression ISO RGD:1349579 6480464 Thapsigargin results in decreased expression of EBF1 mRNA CTD PMID:22378314 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of EBF1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of EBF1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1349579 6480464 trichostatin A results in increased expression of EBF1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1349579 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBF1 mRNA CTD PMID:27188386 triptonide increases expression ISO RGD:732633 6480464 triptonide results in increased expression of EBF1 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:732633 6480464 troglitazone results in decreased expression of EBF1 mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:732633 6480464 Tungsten results in decreased expression of EBF1 mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:732633 6480464 Tunicamycin results in increased expression of EBF1 mRNA CTD PMID:17127020 tunicamycin decreases expression ISO RGD:1349579 6480464 Tunicamycin results in decreased expression of EBF1 mRNA CTD PMID:22378314 valproic acid decreases expression ISO RGD:732633 6480464 Valproic Acid results in decreased expression of EBF1 mRNA CTD PMID:19136453 valproic acid decreases expression ISO RGD:1349579 6480464 Valproic Acid results in decreased expression of EBF1 mRNA CTD PMID:25716160 valproic acid multiple interactions ISO RGD:1349579 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBF1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1349579 6480464 Valproic Acid results in increased expression of EBF1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1349579 6480464 Valproic Acid affects the expression of EBF1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of EBF1 mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:1349579 6480464 Vincristine results in increased expression of EBF1 mRNA CTD PMID:23649840 vorinostat increases expression ISO RGD:1349579 6480464 vorinostat results in increased expression of EBF1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1349579 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBF1 mRNA CTD PMID:27188386 XAV939 decreases expression ISO RGD:732633 6480464 XAV939 results in decreased expression of EBF1 mRNA CTD PMID:27226553